Trial Profile
Clinical Trials Insight: 700028504
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 Nov 2007
Price :
$35
*
At a glance
- Drugs Elpetrigine (Primary)
- Indications Epilepsy; Mood disorders
- Focus Adverse reactions
- 15 Nov 2007 New trial record.